2 results match your criteria: "Hartford Hospital Cardiac Laboratory[Affiliation]"
Outcomes of Transcatheter Aortic Valve Replacement in Patients Treated With Systemic Steroids.
J Invasive Cardiol
January 2022
Division of Interventional Cardiology, Hartford Hospital Cardiac Laboratory, High Building, 80 Seymour Street, Hartford, CT 06115 USA.
Background: Chronic steroid therapy is associated with higher vascular complication rates in patients undergoing transcatheter aortic valve replacement (TAVR). The effect of corticosteroids on aortic annular complications has not been directly assessed in this population.
Methods: A retrospective analysis of 1095 patients undergoing transfemoral TAVR was performed.
Long-term efficacy and safety of sirolimus-eluting vs bare-metal stents.
Conn Med
September 2008
Division of Interventional Cardiology, Hartford Hospital Cardiac Laboratory, 80 Seymour Street, Hartford CT 06115, USA.
Background: Although previous studies have documented persistent clinical benefit of sirolimus-eluting stents (SES)in reducing the need for target vessel revascularization without an increase in myocardial infarction (MI) or mortality, the long-term safety and efficacy of CYPHER stent use in routine clinical practice, including off-label stent implantation, remains uncertain.
Methods: We compared long-term clinical outcomes in 2,550 patients treated with one or more SES with 1,022 patients treated with one or more bare metal or heparin-coated stents (BMS). The study groups included 1,058 SES patients (41.